Oh-e Y, Miyazaki H, Matsunaga Y, Nambu K, Kobayashi N, Hashimoto M
Research Laboratories, Dainippon Pharmaceutical Co. Ltd., Osaka, Japan.
Eur J Drug Metab Pharmacokinet. 1987 Jul-Sep;12(3):183-8. doi: 10.1007/BF03189895.
[14C]Haloperidol decanoate was hydrolysed by partially purified carboxylesterase but not in plasma, blood, lymph and lymphatic liquid. These fluids inhibited the enzyme-mediated hydrolysis of the ester. Within the same incubation period as above, the ester was found hydrolysed to various extents in cell cultures of isolated rat liver cells, of human and rat lymphocytes and of established cell lines (BGM cells, WI-38 cells and L6 cells). Thus, the hydrolysis of the ester was demonstrated in vitro with use of viable cell cultures instead of enzyme preparation. From the time course study on the metabolism of haloperidol decanoate in cell cultures, it was concluded that haloperidol decanoate was first concentrated in the cells and hydrolysed to haloperidol. Based on these results, the metabolic sequences in vivo leading to the formation of active principle haloperidol after intramuscular administration of its decanoate were discussed.
[14C]癸酸氟哌啶醇可被部分纯化的羧酸酯酶水解,但在血浆、血液、淋巴液和淋巴中则不会。这些液体抑制了酶介导的酯水解。在与上述相同的孵育期内,发现该酯在分离的大鼠肝细胞、人和大鼠淋巴细胞以及已建立的细胞系(BGM细胞、WI-38细胞和L6细胞)的细胞培养物中不同程度地被水解。因此,使用活细胞培养物而非酶制剂在体外证明了该酯的水解。通过对细胞培养物中癸酸氟哌啶醇代谢的时间进程研究得出结论,癸酸氟哌啶醇首先在细胞中浓缩并水解为氟哌啶醇。基于这些结果,讨论了肌内注射癸酸酯后在体内导致活性成分氟哌啶醇形成的代谢过程。